Group One Trading, L.P. Neogenomics Inc Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Neogenomics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 9,541 shares of NEO stock, worth $150,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,541
Previous 14,241
33.0%
Holding current value
$150,461
Previous $223,000
40.81%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$310 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$223 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$138 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$106 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$104 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.98B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...